| Title |
Magnesium sulphate and other anticonvulsants for women with pre-eclampsia
|
|---|---|
| Published in |
Cochrane database of systematic reviews, November 2010
|
| DOI | 10.1002/14651858.cd000025.pub2 |
| Pubmed ID | |
| Authors |
Lelia Duley, A Metin Gülmezoglu, David J Henderson-Smart, Doris Chou |
| Abstract |
Eclampsia, the occurrence of a seizure (fit) in association with pre-eclampsia, is rare but potentially life-threatening. Magnesium sulphate is the drug of choice for treating eclampsia. This review assesses its use for preventing eclampsia. |
Twitter Demographics
The data shown below were collected from the profiles of 8 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Venezuela, Bolivarian Republic of | 2 | 25% |
| Colombia | 1 | 13% |
| United Kingdom | 1 | 13% |
| Spain | 1 | 13% |
| Portugal | 1 | 13% |
| Unknown | 2 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 88% |
| Practitioners (doctors, other healthcare professionals) | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 515 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| South Africa | 2 | <1% |
| United Kingdom | 2 | <1% |
| United States | 2 | <1% |
| Ireland | 1 | <1% |
| Canada | 1 | <1% |
| Ethiopia | 1 | <1% |
| Egypt | 1 | <1% |
| New Zealand | 1 | <1% |
| Unknown | 504 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 75 | 15% |
| Student > Master | 74 | 14% |
| Researcher | 55 | 11% |
| Student > Postgraduate | 43 | 8% |
| Student > Ph. D. Student | 35 | 7% |
| Other | 104 | 20% |
| Unknown | 129 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 230 | 45% |
| Nursing and Health Professions | 38 | 7% |
| Social Sciences | 23 | 4% |
| Agricultural and Biological Sciences | 17 | 3% |
| Biochemistry, Genetics and Molecular Biology | 13 | 3% |
| Other | 55 | 11% |
| Unknown | 139 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 53. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 September 2023.
All research outputs
#749,227
of 24,452,594 outputs
Outputs from Cochrane database of systematic reviews
#1,464
of 12,921 outputs
Outputs of similar age
#2,201
of 105,007 outputs
Outputs of similar age from Cochrane database of systematic reviews
#8
of 90 outputs
Altmetric has tracked 24,452,594 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,921 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.6. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 105,007 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 90 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.